Theme: Proteomics: An atlas of expression

Proteomics 2016
Past Report of Proteomics-2015

Proteomics 2016

Theme: Emerging trends with new innovations in proteomics and bioinformatics

Scientific Sessions:

Track1: Proteomics from Discovery to Function

Proteomics is an emerging field that has been highly enabled by the human genome project. Proteins are the products of genes, the machinery of the cells in our bodies. When genes are disrupted, the proteins are also affected. When pathogens infect us, causing disease, proteins play a key role in signaling the presence and ridding us of these invaders. Almost every process that occurs in our cells – from the metabolization of simple sugar to the division of cells – is dependent on proteins for smooth operation. In general, proteomics seeks to detect and quantify as many proteins as possible. To do this, we often employ a very high tech method called mass spectrometry. Protein analysis to yield more direct understanding of function and regulation of genes. The identification of autoantibodies to tumor cell proteins by proteomics approaches has great potential impact on cancer proteomics and biomarker discovery. Proteomics can detect immune-reactivity directed against protein post-translational modifications. Two-dimensional gel based Western blots, protein antigen microarrays, and multiplex ELISA reactions have been applied by our group to antigen based biomarker detection and validation. Microarray technology is usually used for gene expression profiling. It provides a practical method for measuring the expression level of thousands of genes simultaneously. Gene expression profiling of cancers proteomics represents the largest research category using microarrays and appears to be the most robust approach for molecular characterization of cancers such gene expression data allow us to identify genes which are expressed in a given cell type under a particular condition and time, to identify key players or target genes in signaling pathways, to recognize new targets of drugs, to find molecular markers in disease diagnosis. They are more than 4000 universities/institutions who do their research works in the various fields of Proteomics. The global proteomics market was valued at nearly $5.1 billion in 2014 and is growing at a compound annual growth rate (CAGR) of 18.0% to reach a forecast value of $11.6 billion by 2019. The global proteomics market, which covers: technologies, database and software markets, equipment markets, application markets and service markets. Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019. Some of the major players in the market include Thermo Fisher Scientific Corporation (U.S.), Agilent Technologies (U.S.), and Bio-Rad Laboratories (U.S.).

Related conferences:

1.      18th International Conference on Proteomics and Bioinformatics, Istanbul, Turkey

2.      15th Human Proteome Organization World Congress, Taipei, Taiwan.

3.      The 3rd conference on Protein and Proteomics, Beijing, China

4.      6th International conference on Bioinformatics, Valencia, Spain

5.      6th International conference and Expo on Proteomics, Atlanta, USA

Track 2: Mass Spectrometry in Proteome Research

Proteomics is an emerging field that has been highly enabled by the human genome project. Proteins are the products of genes, the machinery of the cells in our bodies. Protein mass spectrometry refers to the application of proteomics mass spectrometry to the study of proteins. Peptide Mass spectrometry is an important emerging method for the characterization of proteins. Mass spectrometry (MS) measures the mass-to-charge ratio of ions to identify and quantify molecules in simple and complex mixtures.MS has become invaluable across a broad range of fields and applications, including proteomics. The development of high-throughput and quantitative MS proteomics workflows within the last two decades has expanded the scope of what we know about protein structure, function, modification and global protein dynamics.

This overview outlines the role of proteomics mass spectrometry in the field of proteomics and reviews MS methodology and instrumentation and touches on sample preparation and liquid chromatography-based separation prior to MS analysis. The rapid development of mass spectrometric technologies applied to protein research has catalysed entirely new experimental approaches and opened up new types of biological questions to experimentation, culminating in the field of proteomics. Two-dimensional gel electrophoresis can be used to create cellular protein maps which give a quantitative and qualitative picture of the proteome databasesPeptide Mass spectrometry is the method of choice for the rapid large-scale identification of these proteomes and their modifications. Proteogenomics uses mass spectrometry data to experimentally validate gene products and to assist in the process of genome annotation and comparison. The global mass spectrometry market is currently witnessing a healthy growth due to the increasing demand for hyphenated and tandem techniques that involve proteomics mass spectroscopy. The application areas include industries such as pharmaceuticals, biotechnology, research, environment testing, and food and beverage, among others. The major players in mass spectrometry market include Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Agilent Technologies (U.S.), Bruker Corporation (U.S.), Waters Corporation (U.S.), Bio-Rad Laboratories (U.S.), Danaher Corporation (U.S.), and Shimadzu Corporation (Japan), among others. In the U.S., the National Institutes of Health funded the University of Georgia with a grant of $1.2 million for biomedical research. In Europe, Germany has increased its funding for research, and in the U.K.; mass spectrometry in proteomics is used in the food testing processes.

Related conferences:

1.      21st International Mass Spectrometry conference, Toronto, Canada

2.      64th American Society for Mass Spectrometry Conference, San Antonio, USA

3.      21st International Mass Spectrometry Conference, Toronto, Canada

4.      2nd International Conference on Current Trends in Mass Spectrometry, Chicago, USA

Track 3: Analytical Genomics

Proteomics is the large-scale study of proteins, particularly their structures and functions. Proteins are vital parts of living organisms, as they are the main components of the physiological metabolic pathways of cells. Biological databases are libraries of life sciences information, collected from scientific experiments, published literature, high-throughput experiment technology, and computational analysis. They contain information from research areas including genomics, proteomics, metabolomics, microarray gene expression, and phylogenetics. Genome sequencing of humans and other organisms has led to the accumulation of huge amounts of data, which include immunologically relevant data. The National Cancer Institute (NCI)Clinical Proteomics Tumor Analysis Consortium is applying the latest generation of proteomic technologies to genomically annotated tumors from The Cancer Genome Atlas (TCGA) program, a joint initiative of the NCI and the National Human Genome Research Institute. By providing a fully integrated accounting of DNA, RNA, and protein abnormalities in individual tumors, these datasets will illuminate the complex relationship between genomic abnormalities and cancer phenotypes, thus producing biologic insights as well as a wave of novel candidate biomarkers and therapeutic targets amenable to verification using targeted mass spectrometry methods. The global bioinformatics market accounted for $4.2 billion in 2014 and is poised to reach $13.3 billion by 2020 at a CAGR of 20.9% from 2015 to 2020. The bioinformatics platforms product segment is expected to witness the fastest growth during the forecast period. North America accounted for the largest market share of the bioinformatics market, followed by Europe, in 2014. However, Asian and Latin American countries represent emerging markets, owing to a rise in research outsourcing by pharmaceutical giants, increasing number of contract research organizations (CROs), rise in public and private sector investment, and growing industry -academia partnerships. The major players in the bioinformatics market are Affymetrix, Inc. (U.S.), Life Technologies Corporation (U.S.), Illumina, Inc. (U.S.), and QIAGEN (The Netherlands).

 Related Conferences:

1.      7th International Conference on Bioinformatics Models, Methods, and Algorithms, Rome, Italy

2.      The Fourteenth Asia Pacific Bioinformatics Conference, San Francisco Bay Area, United States

3.      Lorne Genome Conference, Victoria, Australia

4.      3rd International Conference on Genomics and Pharmacogenomics, San Antonio, USA

5.      6th International conference on Bioinformatics, Valencia, Spain

Track 4: Molecular Modelling and Drug Design

Molecular modelling encompasses all theoretical methods and computational techniques used to model or mimic the behaviour of molecules. Molecular modelling methods are now routinely used to investigate the structure, dynamics, surface properties and thermodynamics of inorganic, biological and polymeric systems. Molecular Modelling and Drug Design has evolved a great deal over the past 30 years. Modelling of proteins mass and bio molecular targets approximation to QSAR. Recent applications of density functional proteomics theory and molecular dynamics in relevant systems are reviewed. Damage to DNA induces several cellular responses and all DNA repair mechanisms. Focused on development of novel therapeutics also emerging chemistry in drug discovery and smart drug delivery, a method of delivering medication to a patient. The average cost of developing new drug molecules and the time taken to market them is pretty high. Today, almost every multi-national drug company and Contract Research Organization (CRO) involved in drug discovery has adopted computational methodology. There are numerous societies, organizations, institutions that are around 590+ who involved in the study of molecular modelling and drug design as they conduct many proteomics conferencesproteomics workshops as well as proteomics meetings. Around more than 1000+ people including researchers, doctorates, delegates, technicians from Universities, biological companies, laboratories, research and pharmaceutical companies were into the molecular modelling research. Around 20+ resources and research groups, journal group acts as funding groups to support this field. The bioinformatics sector is segmented into medical bioinformatics, animal bioinformatics, agriculture bioinformatics, academics and others. The Medical bioinformatics was and is forecast to be the highest revenue generating market through 2020. This was due to the increasing application of drug discovery and development using bioinformatics tools, which were also used in the preventive medicine and gene therapy. The global market for drug discovery technologies reached nearly $39.5 billion and $46.5 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.3% to nearly $79.5 billion for the period 2014-2019.

Related Conference:

1.      Structure Based Drug Design Conference, Carlsbad (US)

2.      Recent Developments in Medical Biotechnology and Structure Based Drug Designing, Guwahati, India

3.      18th International Conference on Molecular Modelling in Drug Design and Biotechnology, London, United Kingdom

4.      Medicinal chemistry & Computer Aided Drug Designing, Chicago, USA

5.      Drug Discovery and Designing, Istanbul, Turkey

Track 5:Systems Biology

To understand complex biological molecular proteomics and systems requires the integration of experimental and computational research provides a powerful foundation from which to address critical scientific questions. Computational systems biology addresses questions fundamental to our understanding of life, yet progress here will lead to practical innovations in medicine, drug discovery and engineering. Insisting the value of high quality protein-protein interaction networks for systems biology. Networks contain a large amount of useful information for the functional proteomics characterization of protein mass. The recent revolution in high-throughput technologies offers an exciting opportunity to study such complex biological systems by new approach called systems biology. A large part of the incentive for using machine learning techniques in this area comes from the incompleteness of detailed knowledge. We intend to introduce some fundamentals of molecular proteomics systems biology and machine learning and present a current state of the art of the machine learning applied to molecular proteomics and systems biology. Genome sequencing technology has led to many recent scientific breakthroughs. The publication of the human genome sequence is the groundwork for further assessment of post-transcriptional and post-translational events occurring in a human cell. Human genome sequence information reveals that genome sequences from person to person are almost (99.9).The completion of the human genome sequencing projects is possibly one of the major advances in biology. This market search report focuses on the current and future applications of Systems Biology. The systems biology market is rapidly evolving, with various technological advancements that have resulted in a paradigm shift within the market the medical application segment accounted for a major share of the systems biology applications market in 2013. North America accounted for the largest share of the global systems biology market, followed by Europe, Asia, and the Rest of the World. In the coming years, Europe is expected to witness the highest growth rate. According to this systems biology market report, the industry is expected to reach $5,630.4 Million by 2018 from $1,923.1 Million in 2013, growing at a CAGR of 24% during the forecast period.

Related Conferences:

1.      The 16th International conference on Systems Biology, Barcelona, Spain

2.      18th International Conference on Systems Biology, Zurich, Switzerland

3.      From Functional Genomics to Systems Biology, Heidelberg, Germany

4.      International Conference on Systems Biology, Biopolis, Singapore

5.      International Conference on Systems in Medicine and Biology, Kharagpur, India

Track 6:Machine Learning in Bioinformatics

Machine learning is preferred approach to Medical outcomes analysis, Computational biology. Aim is to study the theory, implement them and application of computational techniques to problems in biology and medicine. Improves with experience through data, knowledge, experimentation and analysing data from High-throughput methods for gene expression. Providing a comprehensive introduction to the fields of Pattern Recognition and Machine Learning. Discussing about the machine learning tools and techniques how to use them. Proposing an ensemble technique in predicting protein mass secondary structure by Machine learning approach. Supervised learning models such as support vector machines with associated machine learning algorithms. Machine Learning Markets which provide mechanisms for building large scale machine learning models from component parts that trade information via purchases and sales in combinatorial information markets. Recently, prediction markets have shown considerable promise for developing flexible mechanisms for machine learning. We have been working to show that machine learning markets can capture many of the standard compositional structures in machine learning.

Related Conferences:

1.      33rd International Conference on Machine Learning, New York, USA

2.      12th International Conference on Machine Learning and Data Mining MLDM 2016, New York, USA

3.      The Thirtieth Annual Conference on Neural Information Processing Systems, Barcelona, Spain

4.      8th International Conference on Machine Learning and Computing, Hong Kong

5.      18th International Conference on Machine Learning and Pattern Recognition, London, United Kingdom

Track 7: Functional Genomics

Genomics is the new science that deals with the discovery and noting of all the sequences in the entire genome of a particular organism. The genome can be defined as the complete set of genes inside a cell. Functional proteomics genomics is a field of molecular biology that attempts to make use of the vast wealth of data produced by genomic and transcriptomic projects (such as genome sequencing projects and RNA-seq) to describe gene (and protein) functions and interactions. McDonnell Genome Institute is applying next generation sequencing technology to analyse the genomes of these organisms and characterize the communities they form in healthy and diseased individuals. This research could ultimately provide doctors with new diagnostic and therapeutic approaches for a number of diseases. Metagenomics refers to the study of genomic DNA obtained from microorganisms that cannot be cultured in the laboratory. This represents the vast majority of terrestrial microorganisms. Microbial populations occur in every biological niche on earth. Recent advances in DNA sequencing have revolutionized the field of genomics, making it possible for even single research groups to generate large amounts of sequence data very rapidly and at a substantially lower cost. These high-throughput sequencing technologies make deep transcriptome sequencing and transcript quantification, whole genome sequencing and resequencing available to many more researchers and projects. The global market for genomics is expected to reach USD 22.1 billion by 2020, growing at an estimated CAGR of 10.3% from 2014 to 2020, according to a new study by Grand View Research, Inc. Global genomics market is forecasted to be worth 22.1 Billion by 2020.

Related conferences:

1.      13th International Symposium on Rice Functional Genomics, Wuhan, China

2.      Lorne Genome Conference, Victoria, Australia

3.      3rd International Conference on Genomics and Pharmacogenomics, San Antonio, USA

4.      Human Genome Meeting, Houston, USA

5.      13th European Conference on Fungal Genetics, la villette, Paris

Track 8: Recent Advancements in Proteomics

Proteomics applications is the large-scale study of proteins, particularly their structure and functions, including detection, identification, measurement of their concentration, characterization of modification, characterization of protein-protein interaction and regulation. Proteomics applications research includes the characterization of protein mixtures in order to understand complex biological systems and determine relationships among proteins, their functions, and protein-protein interactions. Recently, genomic and proteomic technologies have evolved rapidly in cancer proteomics research. Genomic technologies allow us to monitor thousands of gene expression profiles simultaneously and evaluate interactions of candidate genes to obtain a global view of cancerous tissue in a single unbiased experiment. Mass spectrometry in proteomics is a sensitive technique used to detect, identify and quantitate molecules based on their mass and charge. Our desire to understand the proteome databases has led to new technologies that push the boundary of mass spectrometry capabilities, which in return has allowed mass spectrometry to address an ever-increasing array of biological questions. Recent successes illustrate the role of mass spectrometry-based proteomics as an indispensable tool for molecular and cellular biology and for the emerging field of systems biology. Neuroproteomics is the study of the protein analysis complexes and species that make up the nervous system. These proteins interact to make the neurons connect in such a way to create the intricacies that nervous system is known for. Neuroproteomics is a complex field that has a long way to go in terms of profiling the entire neuronal proteome. Meta-analysis comprises statistical methods for contrasting and combining results from different studies in the hope of identifying patterns among study results, sources of disagreement among those results, or other interesting relationships that may come to light in the context of multiple studies.

Related conferences:

1.      18th International Conference on Proteomics and Bioinformatics, Istanbul, Turkey

2.      15th Human Proteome Organization World Congress, Taipei World Trade Center, Taiwan

3.      The 3rd conference on Protein and Proteomics, Beijing, China

4.      21st International Mass Spectrometry conference, Toronto, Canada

5.      64th American Society for Mass Spectrometry Conference, San Antonio, USA

Track 9: Recent Advancements in Bioinformatics

About the Gene therapy, an experimental technique that uses genes to treat or prevent disease. Embracing the latest advances in molecular medicines and targeted drugs designed to interfere with specific molecule. Monitoring of new antibiotic resistance elements that exploit the power of the genome revolution. Large-scale meta-analysis of genome-wide association data identifies new risks in this field. Supports Database building and management that includes connecting functional genomic data with pathways and networks, statistical aspects of the research and the need for  researchers which employ tools to simplify the management of data. The field of clinical proteomics and bioinformatics includes development of personalized healthcare, medication and therapies development of bioinformatics methodologies for clinical proteomics research, and human databases. a new way to focus on the combination of clinical measurements and signs with human tissue-generated bioinformatics. Genome sequencing refers to the process of identifying the regions of genomic DNA that encode genes the process of subjecting a DNA, RNA or peptide mass spectrometry sequence to analytical methods to understand its features, function, structure, or evolution focused on deciphering the important information encoded in the human and other genomes. Molecular Phylogenetics and Evolution is dedicated to the studies that advance our understanding of phylogeny and evolution. Encourages new findings on or insights into evolutionary processes and mechanisms as expressed at the molecular level. Coming to programming languages Perl and Python both acts specially as bioinformatics resources. It’s a tool for Automated Analysis of Biological Sequence Data and manipulating the bioinformatics data it is a distributed collaborative effort to develop Python libraries and applications which address the needs of current and future work in bioinformatics. The bioinformatics market is expected to grow to $12.86 billion by 2020 with a CAGR of 21.2% during 2014-2020.The major factors driving the bioinformatics market is the need for integrated data, rising demand for drug development and discovery. The reason to study this market is to understand the current trends and applications in the bioinformatics field along with in depth analysis of the segments that follows. Bioinformatics Technology and Services, Application, Sector, Geographic, Competitive Landscape Market Analysis. In the past, the R&D activity in the biotechnology and pharmaceutical industry had a restrictive budget. However, due to the advancement in the IT solutions, the cost involved in the R&D activity has become cost and time efficient.

Related Conferences:

1.      7th International Conference on Bioinformatics Models, Methods, and Algorithms, Rome, Italy

2.      The Fourteenth Asia Pacific Bioinformatics Conference, San Francisco Bay Area, United States

3.      The 3rd conference on Protein and Proteomics, Beijing, China

4.      33rd International Conference on Machine Learning, New York, USA

5.      12th International Conference on Machine Learning and Data Mining MLDM 2016, New York, USA

6.      The Thirtieth Annual Conference on Neural Information Processing Systems, Barcelona, Spain

7th International Conference and Expo on Proteomics which  is going to be held during October 24-26, 2016 at Rome, Italy which includes central topics on Mass Spectrometry in Proteome Research, Molecular Modelling and Drug Design, Systems Biology, Functional genomics, and Recent Advancements in Proteomics and Bioinformatics. OMICS International Organizes 300+ conferences, 500+workshops and 200+symposiums on Clinical, Medicine, Pharma and Science & Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more scientific societies and Publishes 500 open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Proteomics market analysis has its growth in case of Proteomics equipment’s and technologies this has made enormous progress in past few years, and according to the Market Research, value of proteomics market was $9.3 billion in 2012, and is expected to reach $21.63 billion by 2018, at a Compound Annual Growth Rate of 15.1%. Europe accounts for the second-largest share in the global proteomics market, in which Spain is one of the leading contributing states. Valencia is considered to be a hot spot for various researches which are carried out in the field of Proteomics.

Proteomics refers to the study of proteomes, but is also used to describe the techniques used to determine the entire set of proteins of an organism or system, such as protein purification and mass spectrometry. Proteomics is an emerging field that has been highly enabled by the human genome project. Proteins are the products of genes, the machinery of the cells in our bodies. When genes are disrupted, the proteins are also affected. When pathogens infect us, causing disease, proteins play a key role in signaling the presence and ridding us of these invaders. Almost every process that occurs in our cells – from the metabolization of simple sugar to the division of cells – is dependent on proteins for smooth operation. In general, proteomics seeks to detect and quantify as many proteins as possible.



OMICS International takes a great pride in announcing the “5th International Conference on Proteomics & Bioinformatics” (Proteomics-2015) which was held in Valencia, Spain, during 01-03 September, 2015.

Proteomics-2015 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various newfangled topics related to the field of proteomics and bioinformatics. The extremely illustrious conference hosted by OMICS International was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 25 countries around the world. 

The conference aimed a parallel rail with theme “Emerging trends with new innovations in proteomics and bioinformatics”. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Proteomics from Discovery to Function, Mass Spectrometry in Proteome Research, Molecular Modeling & Drug Design, Recent advancements in Proteomics & Bioinformatics, to mention a few. The three days event implanted a firm relation of upcoming strategies in the field of Proteomics, Bioinformatics and Mass Spectrometry Technology with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

The Organizing Committee would like to thank the moderators Dr. Peter Nilsson, KTH-Royal Institute of Technology, Sweden, Dr. Alex Bayes, Biomedical Research Institute Sant Pau, Spain and Dr. Tiziana Bonaldi, European Institute of Oncology, Italy for their contributions which resulted in smooth functioning of the conference.

The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The highlights of the conference were the keynote forum by prominent scientists, Peter Nilsson, KTH-Royal Institute of Technology, Sweden; Ida Pucci Minafra, University of Palermo, Italy; Magnus S Magnusson, University of Iceland, Iceland; Laszlo Takacs, Biosystems International, Hungary; gave their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.

OMICS International is prerogative to thank the Organizing Committee Members, Keynote speakers, Chair and Co-chairs on transcribing the plenary sessions and workshops in a diversified and variegate manner to make this conference an enviable artifact.

OMICS International offers its heartfelt appreciation to the exhibitor Arrayjet, collaborator Bioval who supported the conference in every aspect for the awe-inspiring exhibition at the venue. We also express our sincere thanks to all the media partners for the promotion of our event to glory.

We once again thank all the participants for their wonderful contribution towards the event which helped us for successful accomplishment of this event.

OMICS 5th International Conference on Proteomics & Bioinformatics would not have been successful if it has not been supported by international, multi-professional steering committee and coordination of the Journal of Proteomics & Bioinformatics, Journal of Pharmacogenomics & Pharmacoproteomics & Journal of Data Mining in Genomics & Proteomics.

Past Reports  Proceedings  Gallery  


In the presence of inter professional researchers and practitioners involved in the development of high quality education in all aspects of clinical skills,  4th International Conference on Proteomics & Bioinformatics during Aug 04-06, 2014 at Hilton-Chicago/Northbrook, Chicago, USA.

OMICS Group played host to a diverse panel of key members of the Proteomics community from research lab, industry, academia and financial investment practices, discussing the future of Ophthalmology specialties. This event was really aimed for examining where the real Proteomics and Bioinformatics specialties are going in the future and purpose of the event was to provide an opportunity for cross fertilization of ideas and development of ideas, in the field of Proteomics and Bioinformatics.

Proteomics conference the broad info on Proteomics & Genomics like how genes and proteins are originated and their structure, along with Gene expression. While going into deep studies many investigators still view Genome Annotation as a notoriously unreliable and inaccurate process. When research requires studying how the DNA is constructed or simply we can call “DNA Sequencing or DNA Computing” these studies help us to know how genes are related to one on another or from their ancestor’s. This computing is useful for studies of endangered species and their existence on earth.

Proteomics-2014 Organizing Committee would like to thank the Moderator of the conference, Jasmina N Jovanovic, UCL School of Pharmacy, UK who contributed a lot for the smooth functioning of this event.

We are also thank full to all the speakers who made this event a grand success, our special thanks to Dr. Steven Pelech,Kinexus Bioinformatics Corporation, Canada  & Tamar Geiger, Tel Aviv University, Israel  for organizing a free workshop at the conference, many thanks to all the media partners for the promotion of our event.

The highlights of the meeting were the eponymous lectures, delivered Yuanpeng Janet Huang, Rutgers University, USA, SevgiGezici, Texas A&M University, USA, Stefanie Wienkoop, University of Vienna, Austria, Chin ChiewFoan, University of Nottingham, Malaysia, GeetikaSethi, University of Washington, USA, Uma Shankavaram, National Cancer Institute, USA, Jeff Jones, Applied Proteomics Inc., USA, Xusheng Wang, St. Jude Childrens Research Hospital, USA.

Proteomics-2015 is a remarkable event which brings together unique and international academic scientists, leading engineers, universities and industries making the congress a perfect platform to share experience, foster collaborations across industry and academia and evaluate emerging technologies across the globe. Initiation of cross-border co-operations between scientists and institutions will be also facilitated. It unites applications from various scientific disciplines, pushing the frontiers of Proteomics, Bioinformatics, Machine Learning, Systems Biology, Computational Biology and Molecular Modeling and Drug Designing. It represents the huge area where the focus lies with rapid advancement in research in recent years. It is true that fundamental work on Science and Technology has turned up with unexpected momentous discoveries, but more frequently, the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors.

Past Reports  Gallery  


On July 15-17, 2013, OMICS Group Conferences at Courtyard by Marriott Philadelphia Downtown, USA organized its "3rd International Conference on Proteomics & Bioinformatics". This conference was OMICS endeavor to strengthen the future of the Proteomics science together with research scholars, health care professionals, university professors, industrialists, proteomic associations, editorial board members of OMICS journals, and students globally from leading universities.

The Honourable guests & Keynote speakers for the conference were:

Jorg D. Hoheisel, Deutsches Krebsforschungszentrum (DKFZ), Germany
Edward A. Dennis, University of California at San Diego, USA,
Matthew Kuruc, ProFACT Proteomics Inc., USA,
Ray Fyhr, Merck Research Lab, USA,
Sandra L. Rodriguez-Zas, University of Illinois, USA

On Day-1 The Opening ceremony, speech by honourable guests & keynote forum followed by invited lectures by honorable moderator chair & Co-chair of each session. All the other sessions highlighted the current challenges, issues, opportunities, innovations and ideas in proteomics & bioinformatics research, that was reflected by the theme of the conference “Current Trends and Advances in Proteomics & Bioinformatics"  The theme touched upon various topics like

  • Proteomics: An Overview
  • Current Issues on Proteomics and Bioinformatics
  • Molecular and Cellular Proteomics
  • Applications of Proteomics
  • Disease Proteomics
  • Genomics
  • Evolutionary Phylogenetic Networks
  • Bioinformatics in Biopharmaceuticals and Therapeutics
  • Biomedical Informatics
  • Computational Biology
  • Application of Bioinformatics

 This gave a rewarding learning environment to all the attendees.

OMICS “Proteomics- 2013” is known for uplifting the future of Proteomics and Bioinformatics by encouraging students and fellow researchers to present their work through poster presentations. Students participated with great zeal and the best posters were awarded for their efforts and outstanding contribution to the Proteomics and Bioinformatics research.

On Day-2 from all the Poster Presentations, the best poster presentation was awarded.

On Day-3 of conference we had workshop for all attendees by Steven Pelech, President & C.S.O. from Kinexus Bioinformatics Corporation, Canada.

Workshop Title: Using the Open-Access Online SigNET Knowledge Bank for Meta-analysis of Human Protein Expression, Phosphorylation, Kinase-Protein and Kinase-Drug Interactions.

OMICS group wishes to acknowledge all the organizing committee members, chair and co-chair, editorial board members of OMICS group journals, speakers, students, sponsors, exhibitors and media partners in making this event a great success.

Thank you everyone for the enormous exquisite response. This inspires us to continue organizing events and conferences for furthering the Proteomics and Bioinformatics research.

Past Reports  Gallery  


The 2nd International Conference on Proteomics & Bioinformatics, hosted by theOMICS Group was held in July 2-4, 2012 in Embassy Suites Las Vegas, USA. Generous response and active participation were received from the Editorial Board Members of OMICS Group Journals as well as from scientists, researchers and leaders from pharma, government organizations, students who made this conference as one of the most successful and productive events in 2012 from OMICS Group. The conference was carried out through various sessions, in which the discussions were held on the following scientific tracks:

·  Recent Developments in Proteomic Technology

·  Molecular and Cellular Proteomics

·  Human Proteome Technologies

·  Practical Applications of Proteomics in Medicine

·  Disease Proteomics

·  Exploiting Proteome Bioinformatics and Drug Development

·  Biopharmaceuticals and Gene Therapy

·  Biomedical Informatics

·  Data Mining and Computational Biology

·  Applications and Tools for Protein Structure Predictions

The response to 2nd International Conference on Proteomics & Bioinformatics was huge and was attended by about 200 delegates representing 25 countries from different corners of the world. The conference was initiated with a series of invited lectures delivered by both Honorable Guests and members of the Keynote forum. The list included Dr. Rui Chen, Stanford University, USA; Dr. Roshini Shakya, J R Simplot Company, USA; Dr. Steven Fisher, Agilent Technologies, USA; Dr. Katherine Li, USA; Dr. Andrew K. Ottens, Virginia Commonwealth University School of Medicine, USA; Dr. Anja Nohe, University of Delaware, USA; Dr. Sarath Chandra Janga, Indiana University, USA and Dr. Micheelle Hill, University of Queensland, Australia. All the above mentioned Honourable Guests and Keynote speakers gave their energetic and fruitful contributions at Proteomics-2012

All accepted abstracts have been indexed in OMICS Group Journal of Proteomics & Bioinformatics as a special issue. The theme of this conference was on "Advanced Discussions of the Recent Challenges and Opportunities in the Field of Proteomics & Bioinformatics". Based on this, speaker's discussions included many recommendations.

Past Reports  Gallery  

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date October 24-26, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available